Quarterly report pursuant to Section 13 or 15(d)

Stock Plans

v3.23.1
Stock Plans
3 Months Ended
Mar. 31, 2023
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Plans

NOTE 11. STOCK PLANS

Stock-Based Compensation

During the three months ended March 31, 2023 and 2022, the Company granted options to purchase an aggregate of 226,966 and 480,850 shares of its common stock that are subject to time-based vesting conditions, respectively.

The Company valued these stock options using the Black-Scholes Merton option pricing model. The following assumptions were used to compute the grant date fair values of the stock options granted during the three months ended March 31, 2023 and 2022:

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

Expected term (in years)

 

6.8

 

 

6.1

 

Expected volatility

 

91%

 

 

82%

 

Risk-free interest rate

 

3.6%

 

 

1.8%

 

Expected dividend yield

 

 

 

 

 

 

 

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the three months ended March 31, 2023 and 2022 are set forth in the table below:

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

Expected term (in years)

 

0.5 - 2.0

 

 

0.5 - 2.0

 

Expected volatility

 

71% - 101%

 

 

71% - 88%

 

Risk-free interest rate

 

0.1% - 4.8%

 

 

0.2% - 2.4%

 

Expected dividend yield

 

 

 

 

 

 

 

The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below:

 

 

Three Months Ended
March 31,

 

 

2023

 

 

2022

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

Restricted stock units

 

$

2,168

 

 

$

3,432

 

Performance-based stock units

 

 

328

 

 

 

 

Stock options

 

 

971

 

 

 

1,273

 

Employee stock purchase plan

 

 

450

 

 

 

92

 

Common stock issued for services

 

 

 

 

 

19

 

Total stock-based compensation expense

 

$

3,917

 

 

$

4,816

 

 

 

 

 

 

 

Stock-based compensation expense by operating expense grouping:

 

 

 

 

 

 

Cost of revenue

 

$

20

 

 

$

20

 

Sales and marketing

 

 

176

 

 

 

463

 

Research and development

 

 

1,542

 

 

 

1,004

 

General and administrative

 

 

2,179

 

 

 

3,329

 

Total stock-based compensation expense

 

$

3,917

 

 

$

4,816

 

 

 

Stock-based compensation capitalized for internal-use software was $134 and $33 for the three months ended March 31, 2023 and 2022, respectively.

 

Equity Award Activity Under Stock Plans

Performance Stock Units

On January 4, 2023, the Company entered into a consulting agreement (the “Steel Holdings Consulting Agreement”) with Steel Holdings, LLC, an affiliate of Chad Steelberg, our former Chief Executive Officer and current Chairman of the Company’s Board of Directors (the “Board”), as further described in Note 12. In connection with the Steel Holdings Consulting Agreement, on January 11, 2023 the Compensation Committee of the Board (the “Compensation Committee”) approved a grant of 118,460 performance stock units (the “Steel Holdings Consulting PSUs”) that vest upon the achievement of certain performance milestones. The Steel Holdings Consulting PSUs will expire 6 months after the Steel Holdings Consulting Agreement terminates.

On March 16, 2023, the Compensation Committee approved a grant of 170,402 target performance stock units to be granted to the Company’s named executive officers (the “Senior Executive PSUs”). The awards have a grant date of March 31, 2023 and will vest based on the achievement of revenue and non-GAAP net income targets (each equally weighted) for 2023, which achievement shall then be modified (up to a 20% increase or decrease) based on the Company’s relative total shareholder return over a three-year performance period (the “TSR Modifier”), as compared with the S&P Software and Services Select Industry Index. Based on the Company’s performance, the Company’s named executive officers may earn from 0% to 200% of the target number of shares of the Senior Executive PSUs. The Senior Executive PSUs, to the extent earned, will vest on the date the Board certifies the TSR Modifier for the three-year performance period ending December 31, 2025 and the number of Senior Executive PSUs that will vest as of such certification, all of which will occur within 90 days of the end of the performance period ending December 31, 2025. Compensation costs recognized on the Senior Executive PSUs are adjusted, as applicable, for performance above or below the target specified in the award.

The Company’s performance stock unit activity for the three months ended March 31, 2023 was as follows:

 

 

 

 

 

Weighted

 

 

 

 

 

Average Grant

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2022

 

 

 

 

N/A

 

Granted

 

 

288,862

 

 

$

5.88

 

Unvested at March 31, 2023

 

 

288,862

 

 

$

5.88

 

Restricted Stock Units

The Company’s restricted stock unit activity for the three months ended March 31, 2023 was as follows:

 

 

 

 

 

Weighted

 

 

 

 

 

Average Grant

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2022

 

 

1,048,834

 

 

$

15.28

 

Granted

 

 

517,554

 

 

$

6.03

 

Forfeited

 

 

(27,994

)

 

$

22.79

 

Vested

 

 

(361,532

)

 

$

16.71

 

Unvested at March 31, 2023

 

 

1,176,862

 

 

$

12.07

 

 

As of March 31, 2023, total unrecognized compensation cost related to restricted stock units was $10,590, which is expected to be recognized over a weighted average period of 2.17 years.

Performance-Based Stock Options

The activity during the three months ended March 31, 2023 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows:

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2022

 

 

3,762,679

 

 

$

11.15

 

 

 

 

 

 

Exercised

 

 

(7,000

)

 

$

6.11

 

 

 

 

 

 

Expired

 

 

(14,040

)

 

$

5.75

 

 

 

 

 

 

Outstanding at March 31, 2023

 

 

3,741,639

 

 

$

11.18

 

 

5.3 years

 

$

76

 

Exercisable at March 31, 2023

 

 

3,741,639

 

 

$

11.18

 

 

5.3 years

 

$

76

 

 

The aggregate intrinsic value of the options exercised during the three months ended March 31, 2023 and 2022 was $5 and $221, respectively. No performance-based stock options were granted during the three months ended March 31, 2023 and 2022 and no performance-based stock options vested during the three months ended March 31, 2023.

Stock Options

The activity during the three months ended March 31, 2023 related to all other stock options was as follows:

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2022

 

 

5,867,785

 

 

$

14.53

 

 

 

 

 

 

Granted

 

 

226,966

 

 

$

5.31

 

 

 

 

 

 

Exercised

 

 

(12,979

)

 

$

6.11

 

 

 

 

 

 

Forfeited

 

 

(67,559

)

 

$

22.50

 

 

 

 

 

 

Expired

 

 

(33,471

)

 

$

12.57

 

 

 

 

 

 

Outstanding at March 31, 2023

 

 

5,980,742

 

 

$

14.12

 

 

5.6 years

 

$

1,624

 

Exercisable at March 31, 2023

 

 

4,708,690

 

 

$

14.23

 

 

4.6 years

 

$

1,242

 

The weighted average grant date fair value of stock options granted during the three months ended March 31, 2023 and 2022 was $4.21 and $11.36 per share, respectively. The aggregate intrinsic value of the stock options exercised during the three months ended March 31, 2023 and 2022 was $10 and $163, respectively. The total grant date fair value of stock options vested during the three months ended March 31, 2023 and 2022 was $1,584 and $1,085, respectively. At March 31, 2023, total unrecognized compensation expense related to stock options was $11,711 and is expected to be recognized over a weighted average period of 2.6 years.

The aggregate intrinsic values in the tables above represent the difference between the fair market value of the Company’s common stock and the average option exercise price of in-the-money options, multiplied by the number of such stock options.

Employee Stock Purchase Plan

During the three months ended March 31, 2023, a total of 87,895 shares of common stock were purchased under the ESPP. As of March 31, 2023 and December 31, 2022, accrued employee contributions for future purchases under the ESPP totaled $248 and $595, respectively.